摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid | 122033-48-1

中文名称
——
中文别名
——
英文名称
(S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid
英文别名
(S)-10-(2,6-Dimethyl-4-pyridinyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid;(2S)-6-(2,6-dimethylpyridin-4-yl)-7-fluoro-2-methyl-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
(S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid化学式
CAS
122033-48-1
化学式
C20H17FN2O3S
mdl
——
分子量
384.431
InChiKey
DNYDAUUCCWZVJY-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    27
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    95.8
  • 氢给体数:
    1
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • Tricyclic-pyridinylquinoline compounds, their preparation and use
    申请人:Sterling Drug Inc.
    公开号:US04839355A1
    公开(公告)日:1989-06-13
    Fluorinated 10-(2,6-dimethyl-4-pyridinyl)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-d e][1,4]benzoxazine-6-carboxylic acids and -benzothiazine-6-carboxylic acids of the formula ##STR1## wherein R is hydrogen, R' is hydrogen or fluoro, R" is alkyl of 1-3 carbon atoms and X is O or S are superior antibacterial agents.
    氟化的10-(2,6-二甲基-4-吡啶基)-3-甲基-7-氧代-2,3-二氢-7H-吡啶并[1,2,3-d e][1,4]苯并噁嗪-6-羧酸和-苯并噻嗪-6-羧酸,其化学式为##STR1## 其中R为氢,R'为氢或氟,R"为1-3个碳原子的烷基,X为O或S,是优秀的抗菌剂。
  • Method of inhibiting mammalian topoisomerase II and malignant cell
    申请人:Sterling Drug Inc.
    公开号:US05308843A1
    公开(公告)日:1994-05-03
    A method of inhibiting mammalian topoisomerase II and inhibiting the growth and inducing the regression of malignant cells in mammals by the action of a (S)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine or -benzothiazine of the formula ##STR1## wherein R.sub.1 is hydrogen or fluoro, R.sub.2 and R.sub.3 each independently is hydrogen or alkyl having 1 to 4 carbon atoms, and X is O, S or S=O; a pharmaceutically acceptable acid-addition salt thereof; or a salt thereof with a pharmaceutically acceptable cation; and certain novel compounds of formula I.
    一种通过使用(S)-3-甲基-7-氧代-2,3-二氢-7H-吡啶[1,2,3-de][1,4]苯并噁唑或苯并噻唑来抑制哺乳动物拓扑异构酶II并抑制哺乳动物恶性细胞的生长和诱导其退化的方法,该化合物的化学式为##STR1##其中R.sub.1为氢或氟,R.sub.2和R.sub.3各自独立地为1至4个碳原子的氢或烷基,X为O、S或S=O;其药学上可接受的酸加成盐;或其与药学上可接受的阳离子的盐;以及某些新的化合物I的方法。
  • 4-Oxo-3-Quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
    申请人:STERLING WINTHROP INC.
    公开号:EP0306860A2
    公开(公告)日:1989-03-15
    A compound useful as an antibacterial agent compound having the formula: wherein: R is hydrogen or lower alkyl; R′ is hydrogen, fluoro or -SR‴, where R‴ is benzyl, phenyl or lower-alkyl; R˝ is alkyl of 1-3 carbon atoms; X is O or S; or a pharmaceutically acceptable acid-addition salt thereof; or an alkali metal or amine salt of a compound where R is hydrogen as well as processes for the preparation thereof.
    一种可用作抗菌剂的化合物,其式如下 其中 R是氢或低级烷基; R′是氢、氟或-SR‴、 其中 R‴ 是苄基、苯基或低级烷基; R˝ 是 1-3 个碳原子的烷基; X 是 O 或 S; 或其药学上可接受的酸加成盐;或 R 为氢的化合物的碱金属盐或胺盐及其制备工艺。
  • LESHER, GEORGE Y.
    作者:LESHER, GEORGE Y.
    DOI:——
    日期:——
  • US4839355A
    申请人:——
    公开号:US4839355A
    公开(公告)日:1989-06-13
查看更多